Literature DB >> 440207

Management of carcinoid syndrome.

P Bonomi, C Hovey, J R Dainauskas, R Slayton, J Wolter.   

Abstract

Two patients who had severe carcinoid syndrome are presented. In one patient prednisone relieved symptoms for 20 months, and in the second patient chemotherapy appears to have precipitated fatal carcinoid crisis. Changes in mentation, increased frequency and intensity of flushing, and hypotension indicate increased risk of a chemotherapy induced carcinoid crisis. Since prednisone may produce relatively long control of carcinoid syndrome, it should be tried before chemotherapy in patients who have increased risk of carcinoid crisis. If chemotherapy is given, doses should be decreased by 50%, and patients should be followed closely.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 440207     DOI: 10.1002/mpo.2950060111

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  5 in total

1.  Paraneoplastic vasculitic neuropathy related to carcinoid tumor.

Authors:  Suraj Ashok Muley; Kevin Brown; Gareth J Parry
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

2.  Regression of carcinoid tumour with cyproheptadine.

Authors:  A L Harris; I E Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1982-08-14

Review 3.  Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.

Authors:  Jessica E Maxwell; Boris Naraev; Daniel M Halperin; Michael A Choti; Thorvardur R Halfdanarson
Journal:  Ann Surg Oncol       Date:  2022-02-14       Impact factor: 5.344

4.  Chemotherapy for the carcinoid syndrome.

Authors:  A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  Tryptophan in the treatment of carcinoid crisis.

Authors:  A L Harris; I E Smith
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.